Panacea Biotec Limited is India's second largest vaccine producer and a research-based health management company, specializing in prescription products across various therapeutic areas.

The company has a strong R&D background with collaborations with both national and international research organizations, and it holds product patents in multiple countries.

Recent developments include the launch of innovative vaccines, such as the world's first fully liquid wP-IPV pentavalent vaccine, underscoring its leadership in vaccine innovation.

Panacea Biotec has strategically divested certain assets, including pharmaceutical formulation brands to Mankind Pharma, while focusing on its core competencies in vaccines and biotechnology.

Panacea Biotec's facilities have received international certifications and inspections, demonstrating compliance with global health and safety standards, enhancing its export potential.